Iwona P.
- Country
- Poland
- Department
- -
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 143 of 304 partner sites.
Specializations
Respiratory Disease Management
The investigator specializes in treating complex respiratory conditions, with particular emphasis on severe asthma and its management in patients who show inadequate response to standard treatments.
- Treatment-resistant asthma
- Combination therapy approaches
- Bronchodilator effectiveness
Their work encompasses evaluation of innovative inhaler therapies and their impact on lung function improvement.
Pulmonary Fibrosis Research
Demonstrates significant expertise in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis, focusing on novel therapeutic interventions and treatment modalities.
- Interstitial lung diseases
- Advanced fibrosis treatments
- Innovative inhalation therapies
Their research extends to investigating both established and experimental treatments for fibrosing lung conditions.
Chronic Cough Studies
The investigator has developed expertise in treating refractory chronic cough and unexplained chronic cough, exploring new therapeutic options for patients with persistent symptoms.
- Cough frequency assessment
- Long-term treatment outcomes
- Novel therapeutic approaches
Their work includes evaluation of innovative treatments for patients with difficult-to-treat chronic cough conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.